Surescripts to the Food and Drug Administration: Tap into Tech to Hinder Opioid Misuse and Diversion

April 03, 2018

As the nation’s policy makers grapple with how to curb the opioid epidemic, we at Surescripts continue to join the conversation at various forums and offer our assistance and expertise in support of the cause.

At a recent meeting of the Food and Drug Administration’s (FDA) Opioid Policy Steering Committee (OPSC), committee members requested public comments on its efforts to:

  1. Decrease exposure and prevent new addiction
  2. Support the treatment of those with opioid use disorder
  3. Foster the development of novel pain treatment therapies
  4. Improve enforcement and assess benefit-risk

We took this opportunity in a March 16 letter to the committee in which we explained how electronic prescribing for controlled substances (EPCS) and electronic medication history can help improve prescribing behavior and prevent opioid misuse or diversion.

As the nation’s largest health information network, Surescripts connects virtually all electronic health records (EHRs), pharmacy benefit managers, pharmacies and clinicians, plus an increasing number of health plans, long-term and post-acute care organizations and specialty pharmacy organizations.

“Our cross-market experience gives us a unique perspective on the role that health information technology (HIT) can play in providing actionable intelligence to help reduce opioid abuse while ensuring that patients receive quality care and clinically appropriate medications,” the letter said.

And one of the most promising of these technologies is EPCS.

“EPCS can reduce illegal diversion, a significant driver fueling the opioid epidemic … Broad adoption of EPCS would eliminate paper-based fraud. Equally important, it would create electronic records of controlled substance transactions, strengthening surveillance and improving accountability.”

The letter also detailed nationwide and state adoption of EPCS and the many positive results that come with using it.

We at Surescripts are committed to assisting state policymakers who are working to incentivize EPCS, and we recently expressed our support for Congressional bipartisan bills that would require EPCS use under the Medicare Part D program nationwide.

Given the efficacy and impact of EPCS, “[w]e recommend that the Steering Committee support legislative and regulatory efforts to accelerate adoption and use of EPCS by prescribers,” stated the letter.

In addition to EPCS, the letter encouraged the FDA to consider technologies that give prescribers a more complete picture of the medications their patient has received and from whom. Our medication history solution does exactly that, and is an excellent complement to state-based Prescription Drug Monitoring Programs (PDMPs).

There are a number of other technologies can help healthcare practitioners make better informed care decisions while navigating the complexities of the opioid crisis. Having actionable intelligence at the point of prescribing empowers physicians in just about every way imaginable, and the following are some of the technologies that make it possible. 

Surescripts’ record locator and exchange service retrieves and delivers clinical records from all over the U.S., regardless of EHR or health system, allowing a prescriber to quickly assess their patient’s care across multiple settings. Our Record Locator & Exchange service provides access to records for 230 million patients, or virtually the entire U.S. population), and we do so in a way that complies with all applicable privacy laws and security best practices.

Clinical Direct Messaging supports secure communication between clinicians and prescribers who may suspect a particular patient is at-risk for or experiencing opioid use disorder.

And given that one in five patients becomes dependent on opioids with just a ten-day drug therapy, prescribers need to know if their patient is adhering to their medications, i.e. taking the right drugs at the right dosage, or taking medications that may harm them in combination (as in the case of an adverse drug event). Electronic medication adherence alerts that are easy to consume within the EHR help answer these important questions.

We understand that there is no silver bullet and no simple solution to put a stop to the opioids scourge, but we’re confident that technology can help turn the tide.

We commend OPSC’s important work and are honored to contribute to its efforts. Making an impact on the opioid problem calls for all hands on deck—all sectors of society, private and public alike. Together, we can help place the nation on the path to recovery.

Related Articles

January 02, 2019

Laws Requiring the E-Prescribing of Opioids Have Gained Momentum, but Prescriber Adoption is Playing Catch Up

The SUPPORT for Patients and Communities Act, which Congress passed and President Trump signed into law in October, mandates the use of electronic prescribing of controlled substances (EPCS) for all controlled substances under Medicare Part D by January 1, 2021.

October 24, 2018

Surescripts Applauds New Law to Drive Adoption of Technology to Combat the Opioid Epidemic

Surescripts commends Congress for passing and President Trump for signing H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act into law on October 24, 2018. This law will support the broader adoption of existing technology that can help deter prescription fraud, diversion and abuse. Today marks a major milestone in our efforts to combat the opioid epidemic and save lives. Read more...
July 05, 2018

Key Technologies for Fighting Opioid Misuse are Gaining Traction

The statistics are staggering. According to the Centers for Disease Control and Prevention, the opioid epidemic now takes more lives in the U.S. than breast cancer. In addition, American life expectancy at birth declined for the second consecutive year in 2016 due to a dramatic 21 percent rise in the death rate from drug overdoses. Our nation has not experienced a two-year consecutive decline in life expectancy since the early 1960s as a result of an influenza epidemic. Even the worst mortality rate of the AIDS epidemic in 1993 caused American life expectancy to drop for just one year. Read more...